Filipa Mendes is a Principal Researcher (with tenure) at
Universidade de Lisboa, Instituto Superior Técnico, Department of Nuclear
Sciences and Engineering. She completed a PhD in Cellular Biology at the
Faculty of Sciences of ULisboa in December 2004. During her post-doctoral
fellowship at the National Institute of Health in Lisboa, she received two
awards: the Gulbenkian Award “Estímulo à Investigação” and the L'Oréal Medal of
Honour for Women in Science. Her scientific activity takes place at C2TN-Center
for Nuclear Sciences and Technologies, where she is currently the Coordinator
of the thematic strand "Radiopharmaceutical Sciences and Health
Physics" and a member of the Coordinating Commission of the Scientific
Council (CC-CC). She was a Visiting Professor at the Technical University of
Munich, Germany, in the summer of 2023. Since 2023, she has been a member of
the steering committee of the European Working Group on Radiobiology of
Molecular Radionuclide Therapy.
Research Keywords & Expertise
Molecular Imaging
cancer theranostics
Pre-clinical evaluatio...
Advanced cellular mode...
Fingerprints
5%
cancer theranostics
5%
Molecular Imaging
5%
Advanced cellular models
5%
Pre-clinical evaluation of radiopharmaceutical compounds
Short Biography
Filipa Mendes is a Principal Researcher (with tenure) at
Universidade de Lisboa, Instituto Superior Técnico, Department of Nuclear
Sciences and Engineering. She completed a PhD in Cellular Biology at the
Faculty of Sciences of ULisboa in December 2004. During her post-doctoral
fellowship at the National Institute of Health in Lisboa, she received two
awards: the Gulbenkian Award “Estímulo à Investigação” and the L'Oréal Medal of
Honour for Women in Science. Her scientific activity takes place at C2TN-Center
for Nuclear Sciences and Technologies, where she is currently the Coordinator
of the thematic strand "Radiopharmaceutical Sciences and Health
Physics" and a member of the Coordinating Commission of the Scientific
Council (CC-CC). She was a Visiting Professor at the Technical University of
Munich, Germany, in the summer of 2023. Since 2023, she has been a member of
the steering committee of the European Working Group on Radiobiology of
Molecular Radionuclide Therapy.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
